- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06282562
FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients (FeelFit)
FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marieke Blom, Msc
- Phone Number: +31 6 21522442
- Email: m.e.c.blom@amsterdamumc.nl
Study Locations
-
-
-
Amsterdam, Netherlands, 1081 HV
- Recruiting
- VU University Medical Centers, location VUmc
-
Contact:
- Marieke Blom, Msc
- Phone Number: +31621522442
- Email: gripopfitheid@amsterdamumc.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- reduced self-reported physical fitness;
- minimum age of 18 years;
- diagnosed with a primary brain tumor;
- stable disease, i.e. no signs of radiological or clinical tumor progression;
- no oncological treatment for at least two months prior to inclusion;
- able to speak, read and write in Dutch.
Exclusion Criteria:
- Karnofsky Performance Score < 70;
- already participated in a HIIT program < 1 month prior;
- contraindication of exercise.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HIIT
The intervention group will perform High-Intensity Interval Training (HIIT), consisting of two supervised exercise sessions per week on a stationary bike, for 12 weeks. In addition, participants will receive information on general guidelines for weekly physical activity levels and will be asked to keep an exercise diary. |
Individualized High-Intensity Interval Training (HIIT) program with two exercise sessions per week for 12 weeks.
The exercise sessions will be conducted on a stationary bike, with intensity tailored to each participant's maximum exercise capacity.
|
|
No Intervention: Waiting-list
The control group on the waiting list will be given the option to perform High-Intensity Interval Training (HIIT) after their participation in the study. In addition, also participants from the waiting-list control group will receive information on general guidelines for weekly physical activity levels and will be asked to keep an exercise diary. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported physical fitness
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Self-reported physical fitness is measured using the first question of the International Fitness Scale (IFIS) on general physical fitness, on a 5-point scale where a higher score corresponds to better self-reported physical fitness.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported fitness
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
In addition to the first question of the International Fitness Scale (IFIS), the other questions about cardiorespiratory fitness, muscle strength, speed and flexibility will also be asked as secondary outcomes.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
VO2max
Time Frame: Baseline versus post-intervention (12 weeks)
|
Physical fitness defined as the maximal oxygen uptake measured with a cardiopulmonary exercise test.
|
Baseline versus post-intervention (12 weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily physical activity
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
International Physical Activity Questionnaire (IPAQ).
A higher score corresponds to a physically more intense activity.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Health-related quality of life questionnaire
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC-QLQ_C30) consists of 30 items and includes five functional scales, three symptom scales, a global health status/quality of life scale, and several single items assessing additional symptoms.
The subscales are scored from 0-100 with higher scores representing better quality of life, better functioning, or a higher symptom burden.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Perceived functional impairments
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Work and Social Adjustment Scale (WSAS), consisting of 5 questions on a 8-point scale.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Self-efficacy
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Exercise Self-Efficacy Scale (ESES), consisting of 10 questions on a 4-point scale.
A higher score indicates higher exercise self-efficacy.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Mastery
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Pearlin Mastery Scale (PMS), consisting of 7 items on a 4-point scale.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Brain tumor specific quality of life questionnaire
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-BN20, specific for brain tumor patients.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Subjective Happiness
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Subjective Happiness Scale (SHS), consisting of 4 questions on a 7-point scale.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Subjective cognitive functioning
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Functional Assessment of Cancer Therapy - Cognitive Function (FACT-Cog), consisting of 37 items on a 5-point scale.
A higher score means better cognitive functioning.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Subjective cognitive failure
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Cognitive Failure Questionnaire (CFQ), consisting of 25 items on a 5-point scale.
A higher score refers to more cognitive errors.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Fatigue questionnaire
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Checklist Individual Strength (CIS20), consisting of measurements of fatigue severity, concentration problems, reduced motivation, and reduced activity.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Sleep questionnaire
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Pittsburg Sleep Quality Index (PSQI) assesses sleep dysfunction over 1-month interval.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Anxiety questionnaire
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Beck Anxiety Index (BAI), consisting of 21 questions on a 4-point scale.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Self-reported depression questionnaire
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
Beck Depression Index (BDI-PC), consisting of 21 questions on a 4-point scale.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Depression questionnaire
Time Frame: Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
The Center for Epidemiologic Studies Depression questionnaire, consisting of twenty questions regarding symptoms of depression on a 4-point scale.
|
Baseline versus post-intervention (12 weeks) and versus follow-up (12 weeks and 6 weeks follow-up)
|
|
Muscle strength
Time Frame: Baseline versus post-intervention (12 weeks)
|
Hand-held dynamometer
|
Baseline versus post-intervention (12 weeks)
|
|
Subjective physical fitness
Time Frame: Baseline versus post-intervention (12 weeks)
|
FitMax questionnaire, consisting of thee questions about the maximum capacity of walking, climbing, and cycling, estimating the VO2max.
|
Baseline versus post-intervention (12 weeks)
|
|
Objective neurocognitive functioning
Time Frame: Baseline versus post-intervention (12 weeks)
|
Neuropsychological assessment (NPA), assessing different brain functions.
|
Baseline versus post-intervention (12 weeks)
|
|
Objective neurological functioning
Time Frame: Baseline versus post-intervention (12 weeks)
|
Neurological assessment in neuro-oncology scale (NANO).
A quantitative evaluation of 9 relevant neurologic domains.
|
Baseline versus post-intervention (12 weeks)
|
|
Brain imaging (optional)
Time Frame: Baseline versus post-intervention (12 weeks)
|
MRI (magnetic resonance imaging)
|
Baseline versus post-intervention (12 weeks)
|
|
Brain activity (optional)
Time Frame: Baseline versus post-intervention (12 weeks)
|
MEG (magnetoencephalography)
|
Baseline versus post-intervention (12 weeks)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL84223.018.23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise
-
Centre Hospitalier de CorbieRecruitingExercise Training | Cardiac Rehabilitation | Exercise Intolerance | Exercise Intervention | Exercise Adaptations | HFrEF - Heart Failure With Reduced Ejection FractionFrance
-
Bitlis Eren UniversityCompletedExercise Physiology | Exercise ImmunologyTurkey (Türkiye)
-
Hamza KucukCompletedExercise Training | Exercise PhysiologyTurkey (Türkiye)
-
Faculdade de Motricidade HumanaCompletedGreen Exercise | Indoor ExercisePortugal
-
Lindenwood UniversityIncrenovo, LLCRecruitingCognitive Function | Blood Flow | Nitric Oxide | Endurance Exercise | Exercise Performance | Exercise RecoveryUnited States
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedAgeing | Aerobic Exercise | Resistance Exercise | Combined ExercisePortugal
-
Universidad Rey Juan CarlosCompletedEndurance Exercise | Running Performance | Exercise PhysiologySpain
-
Istanbul Sabahattin Zaim UniversityT.C. Dumlupınar ÜniversitesiCompletedExercise Ergogenics | Recovery Methods | Carnitine Ingestion | Exercise Fatigue | Exercise and RecoveryTurkey (Türkiye)
-
Hasan Kalyoncu UniversityNot yet recruiting
-
University of HawaiiKlein Buendel, Inc.CompletedMomZing Exercise Videos Online | Standard Exercise DVDUnited States
Clinical Trials on High-Intensity Interval Training (HIIT)
-
Wroclaw University of Health and Sport SciencesActive, not recruitingPhysical Activity | Blood Pressure | Cardiorespiratory Fitness | Adipose Tissue | AdolescentsPoland
-
Université de SherbrookeRecruiting
-
Mayo ClinicActive, not recruitingCardiac RehabilitationUnited States
-
Karolinska University HospitalKarolinska InstitutetUnknownDermatomyositis | PolymyositisSweden
-
Wu JiarunCompletedBurnout,Motivation,Stress,Mental ToughnessMalaysia
-
McMaster UniversityCompleted
-
Chang Gung Memorial HospitalCompletedHeart Failure | Morality | Remodeling, VentricularTaiwan
-
Brock UniversityCompletedCardiovascular Diseases | Metabolic SyndromeCanada
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedKnee OsteoarthritisUnited States
-
Karolinska InstitutetRecruitingOverweight | Type 1 DiabetesSweden